The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
Open accessAbstract
Cerebrovascular disease and vascular risk factors are associated with Alzheimer's disease, but the evidence for their association with other neurodegenerative disorders is limited. Therefore, we compared the prevalence of cerebrovascular disease, vascular pathology and vascular risk factors in a wide range of neurodegenerative diseases and correlate them with dementia severity. Presence of cerebrovascular disease, vascular pathology and vascular risk factors was studied in 5715 cases of the National Alzheimer's Coordinating Centre database with a single neurodegenerative disease diagnosis (Alzheimer's disease, frontotemporal lobar degeneration due to tau, and TAR DNA-binding protein 43 immunoreactive deposits, α-synucleinopathies, hippocampal sclerosis and prion disease) based on a neuropathological examination with or without cerebrovascular disease, defined neuropathologically. In addition, 210 'unremarkable brain' cases without cognitive impairment, and 280 cases with pure cerebrovascular disease were included for comparison. Cases with cerebrovascular disease were older than those without cerebrovascular disease in all the groups except for those with hippocampal sclerosis. After controlling for age and gender as fixed effects and centre as a random effect, we observed that α-synucleinopathies, frontotemporal lobar degeneration due to tau and TAR DNA-binding protein 43, and prion disease showed a lower prevalence of coincident cerebrovascular disease than patients with Alzheimer's disease, and this was more significant in younger subjects. When cerebrovascular disease was also present, patients with Alzheimer's disease and patients with α-synucleinopathy showed relatively lower burdens of their respective lesions than those without cerebrovascular disease in the context of comparable severity of dementia at time of death. Concurrent cerebrovascular disease is a common neuropathological finding in aged subjects with dementia, is more common in Alzheimer's disease than in other neurodegenerative disorders, especially in younger subjects, and lowers the threshold for dementia due to Alzheimer's disease and α-synucleinopathies, which suggests that these disorders should be targeted by treatments for cerebrovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, vascular pathologic signs have been found in 79.9% of AD patients.134”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [134]
In the citing paper
“Moreover, neuropathological studies indicate that early cerebrovascular disorder increases risk for dementia including AD (29) and is associated with AD and other neurodegenerative disorders independently of mixed dementias including vascular dementia (593).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [593]
In the citing paper
“In addition to the classic hallmark pathology, A 𝛃 plaques, hyperphosphorylated tau neurofibrillary tangles, and neuron loss, increasing evidence supports that early cerebrovascular dysfunction contributes to AD pathophysiology and cognitive impairment (29, 285, 418, 421, 429, 569, 571, 593, 682, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [593]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [101]
In the citing paper
“Recent clinical-pathological studies have highlighted the role of cerebrovascular disease, not only as a primary cause of cognitive impairment, but also as an adjuvant to the expression of dementia caused by other factors, including AD and other neurodegenerative pathologies (Gorelick et al., 2011; Schneider et al., 2007a; Toledo et al., 2013).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Toledo et al., 2013
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mixed-Effects Models in Sand S-PLUS
Pinheiro, J. C., & Bates, D. M. (2000) · Statistics and Computing · doi:10.1007/978-1-4419-0318-1 · Cited by 11,187
Mixed-Effects Models in S and S-PLUS
(2001) · Technometrics · doi:10.1198/tech.2001.s574 · Cited by 9,278
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Self-citation(2010) · Encyclopedia of Research Design · doi:10.4135/9781412961288.n40 · Cited by 1,995
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Self-citationBeach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103 · cited 1×
“For instance, 40% of patients with clinically diagnosed FTD are found to have a neuropathological diagnosis of Alzheimer’s disease on post-mortem examination (Beach et al., 2012; Nelson et al., 2012; Toledo et al., 2012b).”
BackgroundSelf-citationConsensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
Mixed-Effects Models in S and S-PLUS
(2000) · Statistics and Computing · doi:10.1007/b98882 · Cited by 930
The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set
Beekly, D. L., Ramos, E. M., Lee, W. W., Deitrich, W. D., Jacka, M. E., Wu, J., Hubbard, J. L., Koepsell, T. D., Morris, J. C., & Kukull, W. A. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318142774e · Cited by 907
Self-citationThe Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery
Weintraub, S., Salmon, D., Mercaldo, N., Ferris, S., Graff-Radford, N. R., Chui, H., Cummings, J., DeCarli, C., Foster, N. L., Galasko, D., et al. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318191c7dd · Cited by 888
Self-citationBrain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674
Neuropathologic substrates of Parkinson disease dementia
Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. ‐., Leverenz, J. B., Montine, T. J., Duda, J. E., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23659 · Cited by 518
Self-citationNeuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.
Beekly, D. L., Ramos, E. M., van Belle, G., Deitrich, W. D., Clark, A. D., Jacka, M. E., & Kukull, W. A. (2004) · PubMed · Cited by 430
Self-citationStatistics for the social and behavioral sciences
Kenny, D. A. (1987) · Cited by 416
Microinfarct Pathology, Dementia, and Cognitive Systems
Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.110.595082 · Cited by 404
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Brain Infarction and the Clinical Expression of Alzheimer Disease
Roman, G. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020045023 · Cited by 350
Staging and natural history of cerebrovascular pathology in dementia
Deramecourt, V., Slade, J. Y., Oakley, A. E., Perry, R. H., Ince, P. G., Maurage, C.-A., & Kalaria, R. N. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8e7f · Cited by 309
Dickson, D. W., Davies, P., Bevona, C., Van Hoeven, K. H., Factor, S. M., Grober, E., Aronson, M. K., & Crystal, H. A. (1994) · Acta Neuropathologica · doi:10.1007/bf00293396 · Cited by 293
Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292
Hippocampal sclerosis in advanced age: clinical and pathological features
Nelson, P. T., Schmitt, F. A., Lin, Y., Abner, E. L., Jicha, G. A., Patel, E., Thomason, P. C., Neltner, J. H., Smith, C. D., Santacruz, K. S., et al. (2011) · Brain · doi:10.1093/brain/awr053 · Cited by 279
Prevalence of dementia disorders in the oldest-old: an autopsy study
Jellinger, K. A., & Attems, J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0654-5 · Cited by 276
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Jellinger, K. A., & Attems, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0347-5 · Cited by 268
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons
Schneider, J. A., Boyle, P. A., Arvanitakis, Z., Bienias, J. L., & Bennett, D. A. (2007) · Annals of Neurology · doi:10.1002/ana.21142 · Cited by 264
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias
Yarchoan, M., Xie, S. X., Kling, M. A., Toledo, J. B., Wolk, D. A., Lee, E. B., Van Deerlin, V., Lee, V. M. Y., Trojanowski, J. Q., & Arnold, S. E. (2012) · Brain · doi:10.1093/brain/aws271 · Cited by 262
Self-citationSensitivity and specificity of newly proposed clinical criteria for possible vascular dementia
Gold, G., Giannakopoulos, P., Montes-Paixao, C., Herrman, F. R., Mulligan, R., Michel, J. P., & Bouras, C. (1997) · Neurology · doi:10.1212/wnl.49.3.690 · Cited by 247
Cognitive impact of subcortical vascular and Alzheimer’s disease pathology
Chui, H. C., Zarow, C., Mack, W. J., Ellis, W. G., Zheng, L., Jagust, W. J., Mungas, D., Reed, B. R., Kramer, J. H., DeCarli, C. C., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21009 · Cited by 247
Does vascular pathology contribute to Alzheimer changes?
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.032 · Cited by 239
Mirra, S. S. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00058-4 · Cited by 236
Shapira, I. L. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0118 · Cited by 233
Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohort
Dolan, H., Crain, B., Troncoso, J., Resnick, S. M., Zonderman, A. B., & Obrien, R. J. (2010) · Annals of Neurology · doi:10.1002/ana.22055 · Cited by 231
AD lesions and infarcts in demented and non‐demented Japanese‐American men
Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., Nelson, J., Hardman, J., Masaki, K., Vogt, M. R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20318 · Cited by 230
White matter lesions in Parkinson disease
Bohnen, N. I., & Albin, R. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.21 · Cited by 224
Clinicopathological Validation Study of Four Sets of Clinical Criteria for Vascular Dementia
Gold, G., Bouras, C., Canuto, A., Bergallo, M. F., Herrmann, F. R., Hof, P. R., Mayor, P.-A., Michel, J.-P., & Giannakopoulos, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.82 · Cited by 217
Multiple factor analysis and clustering of a mixture of quantitative, categorical and frequency data
Bécue-Bertaut, M., & Pagès, J. (2008) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2007.09.023 · Cited by 215
CSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182
Self-citationIntracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia
Roher, A. E., Tyas, S. L., Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Emmerling, M. R., Garami, Z. F., Bëlohlávek, M., Sabbagh, M. N., Sue, L. I., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.228 · Cited by 159
Vascular disease and dementias: Paradigm shifts to drive research in new directions
Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. ‐., & Arnold, S. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.02.007 · Cited by 150
Self-citationClinical and Neuropathological Characteristics of Hippocampal Sclerosis: A Community-Based Study
Leverenz, J. B., Agustin, C. M., Tsuang, D. W., Peskind, E. R., Edland, S. D., Nochlin, D., DiGiacomo, L., Bowen, J. D., McCormick, W. C., Teri, L. L., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.7.1099 · Cited by 148
Self-citationPrevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study
Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0676-3 · Cited by 144
Toledo, J. B., Toledo, E., Weiner, M. W., Jack, C. R., Jagust, W., Lee, V. M. ‐., Shaw, L. M. J., & Trojanowski, J. Q. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.008 · Cited by 141
Self-citationVisual rating of white matter hyperintensities in Parkinson's disease
Beyer, M. K., Aarsland, D., Greve, O. J., & Larsen, J. O. (2005) · Movement Disorders · doi:10.1002/mds.20704 · Cited by 114
Hippocampal Sclerosis Contributes to Dementia in the Elderly
Corey‐Bloom, J., Sabbagh, M. N., Bondi, M. W., Hansen, L., Alford, M. F., Masliah, E., & Thal, L. J. (1997) · Neurology · doi:10.1212/wnl.48.1.154 · Cited by 113
Mungas, D., Reed, B. R., Ellis, W. G., & Jagust, W. J. (2001) · Archives of Neurology · doi:10.1001/archneur.58.8.1243 · Cited by 109
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction
Marchant, N. L., Reed, B. R., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C., Weiner, M. W., Mungas, D. M., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 106
Ghebremedhin, E., Rosenberger, A., Rüb, U., Vukšić, M., Berhe, T., Bickeböller, H., de Vos, R. A. I., Thal, D. R., & Deller, T. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d88e63 · Cited by 89
Pathological correlates of frontotemporal lobar degeneration in the elderly
Baborie, A., Griffiths, T. D., Jaros, E., McKeith, I. G., Burn, D. J., Richardson, A. M. T., Ferrari, R., Moreno, J. H., Momeni, P., DuPlessis, D., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0765-z · Cited by 84
Dalaker, T. O., Larsen, J. O., Dwyer, M. G., Aarsland, D., Beyer, M. K., Alves, G. W., Brønnick, K., Tysnes, O., & Zivadinov, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.020 · Cited by 77
Selected Findings from the Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Wilson, R. S., Arvanitakis, Z., Boyle, P. A., de Toledo-Morrell, L., & Schneider, J. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129007 · Cited by 69
Small‐vessel disease in patients with Parkinson's disease: A clinicopathological study
Schwartz, R. S., Halliday, G. M., Cordato, D. J., & Kril, J. J. (2012) · Movement Disorders · doi:10.1002/mds.25112 · Cited by 66
Jellinger, K. A., & Attems, J. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000327360 · Cited by 65
Choi, S.-A., Evidente, V. G. H., Caviness, J. N., Shill, H. A., Sabbagh, M. N., Connor, D. J., Hentz, J. G., Adler, C. H., & Beach, T. G. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0620-2 · Cited by 51
Validation of clinical criteria for possible vascular dementia in the oldest-old
Bacchetta, J.-P., Kövari, E., Merlo, M. C. G., Canuto, A., Herrmann, F. R., Bouras, C., Gold, G., Hof, P. R., & Giannakopoulos, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.006 · Cited by 38
The impact of silent vascular brain burden in cognitive impairment in Parkinson’s disease
Gonzalez-Redondo, R., Toledo, J. B., Clavero, P., Lamet, I., García‐García, D., de Eulate, M. R. G., Martínez‐Lage, P., & Rodríguez-Oroz, M. C. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03682.x · Cited by 37
Self-citationReuck, J. L. D., Deramecourt, V., Cordonnier, C., Leys, D., Pasquier, F., & Maurage, C. (2012) · Neurodegenerative Diseases · doi:10.1159/000335447 · Cited by 30
Cited by
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728
Metadata
- Authors
- Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q.
- Affiliations
- University of Pennsylvania (US)
- University of Washington (US)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-10
- Volume
- 136
- Issue
- 9
- Pages
- 2697-2706
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3858112
- OpenAlex
- W2120070267
- Semantic Scholar
- b470677950c6c00bd6d262c34418a6589c2f44b1
- Cited by
- 849
- References
- 66
- Citations by year
- 2026: 48 · 2025: 94 · 2024: 79 · 2023: 67 · 2022: 94 · 2021: 79 · 2020: 77 · 2019: 77 · 2018: 41 · 2017: 46 · 2016: 51 · 2015: 51 · 2014: 33 · 2013: 11
- FWCI
- 34.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (U01AG016976, P30AG010124, AG-10124, U19AG010483)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, vascular risk factors, vascular pathology, dementia severity, synucleinopathies, frontotemporal lobar degeneration, tau protein, TDP-43, prion disease, hippocampal sclerosis, autopsy neuropathology
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Autopsy, Cerebrovascular Disorders, Female, Health Surveys, Humans, Male, Middle Aged, Risk Factors, Sex Factors, United States, Dementia, Vascular, Prevalence, Neurodegenerative Diseases, National Institute on Aging (U.S.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.